Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines - Wikidata - wikimedia - TriplyDB

Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines

Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines

http://www.wikidata.org/entity/Q24599175

about

Non-standard amino acid incorporation into proteins using Escherichia coli cell-free protein synthesis Cell-Free Protein Synthesis: Pros and Cons of Prokaryotic and Eukaryotic Systems Engine out of the chassis: cell-free protein synthesis and its uses Synthetic in vitro circuits Cell-free biology: exploiting the interface between synthetic biology and synthetic chemistry Emerging technology of in situ cell free expression protein microarrays Membrane protein production in Escherichia coli cell-free lysates Synthetic biology outside the cell: linking computational tools to cell-free systems Robust production of recombinant phosphoproteins using cell-free protein synthesis CANDO and the infinite drug discovery frontier Cell-free metabolic engineering: biomanufacturing beyond the cell A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell-free protein synthesis systems Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens.Creating a completely "cell-free" system for protein synthesis.Cell-free protein synthesis: applications come of age.RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates.Cell-free protein synthesis from a release factor 1 deficient Escherichia coli activates efficient and multiple site-specific nonstandard amino acid incorporation.Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system.Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.Optimized extract preparation methods and reaction conditions for improved yeast cell-free protein synthesis.A combined cell-free transcription-translation system from Saccharomyces cerevisiae for rapid and robust protein synthe.Tobacco BY-2 cell-free lysate: an alternative and highly-productive plant-based in vitro translation system.Sealable femtoliter chamber arrays for cell-free biology.Methods to Make Homogenous Antibody Drug Conjugates.Improving cell-free protein synthesis through genome engineering of Escherichia coli lacking release factor 1 pH responsive granulocyte colony-stimulating factor variants with implications for treating Alzheimer's disease and other central nervous system disorders.Cell-free synthetic biology: thinking outside the cell.Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm Cell-free protein synthesis: the state of the art.Cell-free co-production of an orthogonal transfer RNA activates efficient site-specific non-natural amino acid incorporation.H11/HSPB8 Restricts HIV-2 Vpx to Restore the Anti-Viral Activity of SAMHD1.Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain.Cell-free synthesis of functional phospholipase A1 from Serratia sp.A cell-free approach to accelerate the study of protein-protein interactions in vitro.Thrombin-mediated transcriptional regulation using DNA aptamers in DNA-based cell-free protein synthesis.Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.Cell-free synthetic biology for in vitro prototype engineering.The engineering of artificial cellular nanosystems using synthetic biology approaches.

P2860

Q21131315-6615A2F0-5397-4B14-9E39-F48F5A1C7215 Q26782087-A4DD6E59-81F0-4811-A065-A3B8410F7466 Q26994662-CA695F2E-90E3-41D1-B5DF-A8B75850EF26 Q27004099-CB350CC4-4F68-4106-A885-45ED3306B999 Q27004476-DA0F41D4-8108-4306-A0FC-DDABEC33475A Q27006574-6EC7E34B-B19F-4E72-AE82-E972F2BFACFB Q28084758-FA0CE25C-133F-4FFE-8461-0A5069471304 Q28085024-09D0AE16-386A-40C7-BB70-E1CFBBA4A90D Q28267113-8DE995A6-3C62-40BF-A121-2232350D3A1C Q28543019-3EE20779-19F7-4A4B-BFD2-1181CD84646C Q28650572-F582BDAB-B131-4347-8FAC-5C34EE2D28E5 Q28829640-35A4CDD6-7874-4317-9F9A-204F5B3BA50B Q30356933-F80A4184-3F06-4758-91EF-B109C77D46D2 Q30418486-DA266D59-4574-4150-B217-30CBC775CDAD Q30488251-213346B5-9E29-4A8A-9FE7-38D7B6A0FE57 Q33684275-D6D5C82F-A8C7-4E2E-8F51-F382F2A9F8DF Q33780009-1EB63CC0-359C-459E-B628-6AFE2C0D4672 Q33786525-BBE7034A-1224-4E0E-B7B5-E4D5D0970163 Q34179215-05E9B41A-0D07-4189-AC95-72E176A092EE Q34247760-5617C036-DDA9-4AAF-B51C-46F34697A0E5 Q34801579-92D56B6A-E9E6-4984-8928-0E86C82697EF Q35134118-8D59EB57-EE21-481A-AF14-977265C5EA13 Q35179554-4449CB2F-C527-4529-887C-89BADBA7AD37 Q35459400-2628FACD-4397-4CC5-905B-C5747F19BDB8 Q35523479-992AEBE9-9FDD-46AC-98EE-2225542F563D Q35566287-42428AA9-D61C-4571-8456-AF3021C03907 Q35602819-D25BF7AB-2D0D-4B1D-BD89-6D2BD2B3B9A4 Q35878115-51B768FD-BF4E-4CB4-8464-B3ABD2893D04 Q36155247-8C27358D-C81B-4963-AFE8-D8D36424830F Q36478560-12DDAF52-DDF1-4AFE-AC24-9A964834385D Q36557124-203F5989-4E18-4AC5-A598-6CB2343273F4 Q36909733-55FE1098-BB24-4B3C-B796-5863C8DF2428 Q36996391-02330151-34F2-4766-88A5-482D72B3D9EE Q37065681-6C2E4487-89A8-48EA-8625-86C6821CCAE4 Q37139016-2B236F1F-3494-4D8B-9107-25BEE0F679D2 Q37561396-17E6033E-B3F8-4CE8-8F6A-02FF05E4EBAD Q37653016-A8F07F5C-1AF2-4C8D-A829-3E19222E4586 Q37722665-E330D1F9-7E9A-49BD-AA8C-B83BE0680039 Q38158785-81C7A947-D7C2-46AD-8966-CE4CFC1FCDE7 Q38199457-2CD0D607-0EF1-40F8-9CF3-74AC02928F16

P2860

Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines

http://www.wikidata.org/entity/Q24599175

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Microscale to manufacturing sc ...... oduction development timelines

@ast

Microscale to manufacturing sc ...... oduction development timelines

@en

Microscale to manufacturing sc ...... oduction development timelines

@nl

type

label

Microscale to manufacturing sc ...... oduction development timelines

@ast

Microscale to manufacturing sc ...... oduction development timelines

@en

Microscale to manufacturing sc ...... oduction development timelines

@nl

prefLabel

Microscale to manufacturing sc ...... oduction development timelines

@ast

Microscale to manufacturing sc ...... oduction development timelines

@en

Microscale to manufacturing sc ...... oduction development timelines

@nl

P1433

Q24599175-CAA5ABF0-94BD-491D-B58A-FB71E7B7C7D6

P1476

Q24599175-7A9161FE-7A74-4FD1-9B9C-96FF5FE3B55D

P2093

Q24599175-0952E607-3565-4D89-BEF1-39A127B55344

Q24599175-0ABDD670-5378-4A41-86FA-4D550F592575

Q24599175-1223DCDB-003F-477C-85E7-FD0481DA0C60

Q24599175-315DE111-E106-4880-AA78-BF9C19AC0FA6

Q24599175-7679B201-B05A-4941-99EA-9FCBC9D88650

Q24599175-8AE5EA48-B2DD-48F6-9C50-AA25CAE93DE1

Q24599175-B95944C6-5D13-4BA9-983C-656FEF97F232

Q24599175-C3A26247-FFEC-49CC-92BE-F3C1ADA70346

Q24599175-ED2E90FC-0D18-4B28-ACF7-6576C3771C58

P2860

Q24599175-005FD890-F1E1-49E3-8CE0-28058EB73508

Q24599175-13A6D9CF-6A5D-4F50-AAF1-91D8D9CDD741

Q24599175-21DA39CB-9883-4141-A8BE-12A73DBA93E0

Q24599175-2E6083DE-B3BE-4E72-B93B-1F0AD6355BBF

Q24599175-3280729F-8171-483A-973D-1DC98C759F31

Q24599175-33FCF035-BAF4-4E15-8200-0F4D93A2E542

Q24599175-3BF0FD3F-4D3E-4BE7-AB73-850CA9A85394

Q24599175-3E534396-DC2B-4CFD-AE31-A5FA0EBBD0AC

Q24599175-3FCE6773-EABB-4FDB-B12E-7A72DA5AC630

Q24599175-5CECC93E-EAE7-4725-BAE9-E5F77557E1ED

P304

Q24599175-E79B0D03-CD00-4A24-82E8-E70607345598

P31

Q24599175-32677908-8E11-4F66-BA39-C4485D1DCE67

P3181

Q24599175-BDEFE0F2-779B-4927-807F-63606A7E76CE

P356

Q24599175-27FA1069-D1E9-4A87-A3F0-4DA63E0946A8

P407

Q24599175-DC5EDC11-B568-4076-BA1F-892C62B20949

P433

Q24599175-048EF195-E80E-4F10-9FC0-5B83BF6ED293

P478

Q24599175-BABDAF29-8044-4E65-BEA3-AA3843E565BA

P577

Q24599175-43E0F910-0384-4884-93C4-9E35332BE2B7

P5875

Q24599175-8504FF04-F3DA-4139-8000-743F936D2F04

P698

Q24599175-9FF753DF-3C48-45E7-9002-ABB7B79156F3

P921

Q24599175-CF25DF5A-D5FC-4634-AC85-E574745A8040

P932

Q24599175-83F0600E-AA5E-4923-8024-537370653148

P3181

P356

P1433

Biotechnology and Bioengineering

P1476

Microscale to manufacturing sc ...... oduction development timelines

@en

P2093

Alexander R Steiner

http://www.w3.org/2001/XMLSchema#string

Alpana Naresh

http://www.w3.org/2001/XMLSchema#string

Christopher J Murray

http://www.w3.org/2001/XMLSchema#string

Daniel S Gold

http://www.w3.org/2001/XMLSchema#string

Gang Yin

http://www.w3.org/2001/XMLSchema#string

Henry G Heinsohn

http://www.w3.org/2001/XMLSchema#string

James F Zawada

http://www.w3.org/2001/XMLSchema#string

Junhao Yang

http://www.w3.org/2001/XMLSchema#string

Sushmita M Roy

http://www.w3.org/2001/XMLSchema#string

P2860

Design parameters to control synthetic gene expression in Escherichia coli

Characterizing biological products and assessing comparability following manufacturing changes.

A general method for site-specific incorporation of unnatural amino acids into proteins.

Recent advances in producing and selecting functional proteins by using cell-free translation.

PEGylated murine Granulocyte-macrophage colony-stimulating factor: production, purification, and characterization.

Quantification of proteins and metabolites by mass spectrometry without isotopic labeling.

A continuous cell-free translation system capable of producing polypeptides in high yield.

Combined effects of the signal sequence and the major chaperone proteins on the export of human cytokines in Escherichia coli

Recombinant protein folding and misfolding in Escherichia coli.

A cradle for new proteins: trigger factor at the ribosome.

P304

1570-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

846703

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/BIT.23103

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49851501

http://www.w3.org/2001/XMLSchema#string

P698

21337337

http://www.w3.org/2001/XMLSchema#string

P921

P932

3128707

http://www.w3.org/2001/XMLSchema#string